Skip to main content
. 2016 Feb 3;6:20559. doi: 10.1038/srep20559

Figure 5. H19 knockdown or Shp re-expressing alleviates liver injury induced by Bcl2.

Figure 5

(A) Gross morphology of liver. Low dose: 1 × 1010 viral particles/ml; high dose: 3 × 1010 viral particles/ml. (B) H&E staining in liver sections. A representative image from low dose treatment group is shown. Arrows indicate regions of coagulated hepatocyte necrosis. Scale bar: 200 μm. (C) Gross morphology of spleen (top) and the measurement of spleen weight (bottom). (D) Serum measurements of total or direct bilirubin, ALT, and total BA in low dose groups. (E) qPCR of liver Bcl2, Shp, H19, F4/80 expression in low dose groups. Data are represented as mean ± SD in all panels except (A,B) *P < 0.05 vs. GFP; ¥P < 0.05 vs. Bcl2. (F) qPCR of gene expression in primary hepatocytes transduced with Bcl2. *P < 0.01 vs. GFP. (G) Immunohistochemistry of BCL2 and HNF4α protein localization in Bcl2 overexpressed mouse liver.